FDA expands remote use of patient monitoring devices

Health care providers can now use FDA-cleared non-invasive remote devices to monitor a patient’s vital signs, the agency said today. The new policy, valid only for the duration of the COVID-19 emergency, includes devices capable of enabling remote interactions that measure body temperature, respiratory rate, heart rate and blood pressure. Providers can use the information as a supplement to diagnose or treat COVID-19 or co-existing conditions.